CNBC Stock Blog
- How Stock Investors Can Play Holiday Travel
- 3 Growth Opportunities in Tech: Analyst
- Prep Your Portfolio for Next Week: Stock Pickers
- Global Growth Good for Portfolio: Stock Picker
- Expect Tech Sector to Rise in Q4: Strategist
- Expect a 5-10% Market Pullback: Stock Picker
- 3 Stock Picks for This Volatile Environment: Portfolio Manager
- 3 Financial Stocks May Lead Final Rally: Market Researcher
- Gold's 'Money' Value is $4,000 to $11,000: Market Strategist
- Commercial Real Estate Bottom Near: Market Pro
- How Stock Investors Can Play Holiday Travel
- Time Lapse World Series Is A Great Play
- Hirschhorn: Greed...or Fear
- My Top 10 Tech Toys for the Holidays
- iPhone a Better Gaming Platform Than Android?
- May Day For Dendreon
- 100% Mortgage Financing From USDA
- Holiday Tipping: Who And How Much
- Deep Discounts Should Make It a Very Tech-y Holiday
- The Richest Members of the US Congress
- New Consensus Sees Stimulus Package as Worthy Step
- Wall Street Jobs Slow to Return Despite Record Profits
- Thanksgiving Week Stuffed With Economic News
- Black Friday Deals May Not Signal Retail Comeback
- Investors to Goldman: Be Less Greedy
- UPS Sets New Rates For 2010
- Victoria's Secret Hopes to Rekindle Desire for Lingerie
- 'New Moon' Takes Record $72.7M Box Office Bite
RSS FEED
CNBC News Associate
Stocks continued to struggle on Friday. Could this be the beginning of a real market correction? Mike Rubino, president of Rubino Financial, and Paul Schatz, president of Heritage Capital, discussed how investors should position their portfolios for the end of the third quarter.
“I’ve been bullish for a while and over the next year, we’re going higher,” Schatz told CNBC.
“In the interim, the best chance for the first significant correction since the bull leg began in March is coming up early to mid-October."
"It lasts 4 to 6 weeks and we go down 7 to 17 percent. Other than that, we’ve been on an uptrend and it’s going to be a place to buy," Schatz said.
He believes the correction will be healthy for the markets and relatively small, compared to the 50 percent rally since March.
More Investor Intelligence:
In the meantime, Rubino is worried about consumers refusing to open their wallets to spend.
“Consumer spending has no chance of coming back with unemployment soaring and the housing market continuing to deleverage on a nationwide basis," he said. "I don’t see how consumers are comfortable spending when they’re worried about their assets being depleted.”
Schatz Likes:
S&P Consumer Staples
S&P Utilities
S&P Biotechnology
Rubino Likes:
Proshares Trust [TBT
Loading...
()
]
Proshares Short Oil & Gas [DDG
Loading...
()
]
Proshares Short Financials [SEF
Loading...
()
]
______________________________
Disclosure:
No immediate information was available for Rubino or Schatz.
______________________________
CNBC Slideshows:
______________________________
______________________________
Top Biotech Companies:
Amgen [AMGN
Loading...
()
]
Gilead Sciences [GILD
Loading...
()
]
Biogen [BIIB
Loading...
()
]
Genzyme [GENZ
Loading...
()
]
Amylin Pharmaceuticals [AMLN
Loading...
()
]
______________________________









